Bladder stones are removed by cystolitholapaxy, a cystoscope-based procedure that fragments the stone with laser or mechanical energy and extracts the pieces through the urethra. Larger or harder stones may require percutaneous suprapubic cystolithotomy, and open surgery is reserved for stones over roughly 5 cm or anatomical problems that must be corrected at the same time.

Bladder stones rarely pass on their own. Unlike kidney stones, which travel down a narrow ureter and often exit with urine, bladder stones sit in a reservoir. They form because urine stagnates—usually behind an enlarged prostate, a neurogenic bladder, a bladder diverticulum, or a foreign body—so the same stasis that created the stone keeps it from leaving. Removal therefore has two goals: clear the stone, and fix or manage whatever caused it. (Reference: American Urological Association guideline on bladder stones in adults.)

Fragment-and-extract: how cystolitholapaxy works

Cystolitholapaxy is the default approach for most bladder stones. The surgeon passes a rigid or flexible cystoscope through the urethra into the bladder, usually under general or spinal anesthesia, and views the stone directly. A working channel carries the fragmentation device. Three energy types dominate practice: holmium:YAG laser, which delivers pulsed energy absorbed by water in the stone; pneumatic lithotripsy, which fires a projectile-driven probe; and mechanical lithotrites, which crush the stone between jaws. Electrohydraulic lithotripsy, an older spark-based method, is still used in some centers.

The physics matters more than the brand names. Bladder stones are typically composed of struvite (magnesium ammonium phosphate), calcium oxalate, or uric acid, and struvite stones are often softer and more friable than dense calcium oxalate. A holmium laser fragments by vaporizing a small volume of stone and creating a shock wave; the fiber tip must touch or nearly touch the stone, which is why the surgeon chases the stone around the bladder. Mechanical devices crush rather than vaporize, which works well for brittle stones but can struggle with very hard ones. Fragments are then evacuated through a sheath with suction, grasped with forceps, or washed out. A large stone can generate dozens of fragments, and complete clearance is confirmed by direct vision at the end of the case.

The counterintuitive detail: the anesthesia choice is not trivial. Spinal anesthesia can be preferable in older men with cardiac or pulmonary disease, but it does not relax the bladder as completely as general anesthesia, and a contracted bladder makes stone retrieval harder. Surgeons sometimes deliberately overdistend the bladder with irrigation to create working room—then must avoid overdistension injuring the detrusor muscle.

Quantified context: sizes, times, and success rates

Stone size drives the decision more than any other variable. Stones under about 1 cm are usually straightforward candidates for cystolitholapaxy. Stones of 1–3 cm are routinely fragmented endoscopically, though operative time lengthens with diameter because fragmentation time scales roughly with stone volume, not diameter—doubling the diameter roughly quadruples the volume of stone to clear. Stones above 3–4 cm become progressively harder to clear through a urethral sheath, and many urologists switch to percutaneous or open approaches at that threshold.

Procedure time for cystolitholapaxy commonly runs 30–90 minutes depending on stone burden and hardness, with larger stones pushing past two hours. Hospital stay is typically same-day or one night for uncomplicated cases. Success—defined as complete stone clearance—is high for stones under 3 cm in experienced hands, but reported rates vary by stone composition, device, and whether residual fragments were confirmed at surgery. Rather than cite a single number, treat clearance as conditional: it depends on stone size, hardness, and whether the bladder can be fully inspected.

Recovery follows a predictable curve. Most patients notice blood-tinged urine for 24–72 hours, mild burning on urination for several days, and return to normal activity within a week. A urethral catheter, if placed, is usually removed within 24 hours. Stent placement is not routine for bladder stones the way it is for ureteral stones, because there is no ureter to stent—though a catheter may be left if the bladder was heavily instrumented.

Approach Typical stone size Anesthesia Hospital stay Key limitation
Cystolitholapaxy (laser) Under 3 cm General or spinal Same day to 1 night Fragmentation time; harder stones
Cystolitholapaxy (mechanical) Under 3 cm General or spinal Same day to 1 night Brittle stones only; jaw size
Percutaneous suprapubic 3–5 cm General 1–2 nights Requires skin puncture; bleeding risk
Open cystolithotomy Over 5 cm or Complex anatomy General 1–3 nights Larger incision; longer recovery
Observation Small, asymptomatic None None Stone may grow; infection risk

Edge cases that change the plan

Not every bladder stone is a simple stone. Three situations reliably alter management.

First, bladder outlet obstruction from benign prostatic enlargement. Removing the stone without addressing the obstruction invites recurrence, because urine stasis persists. Many urologists perform a transurethral resection of the prostate or a laser enucleation at the same session as stone removal, or stage the two procedures. The trade-off is longer anesthesia time versus a second operation.

Second, neurogenic bladder from spinal cord injury, multiple sclerosis, or diabetes. These patients often cannot empty the bladder voluntarily and rely on clean intermittent catheterization or an indwelling catheter. Stones in this population are frequently struvite and recur; management includes treating infection and optimizing bladder emptying, not just extracting stone.

Third, bladder foreign bodies and diverticula. Surgical mesh, migrated sutures, or a neglected catheter can serve as a nidus for stone formation, and a stone inside a diverticulum may be inaccessible to a straight cystoscope. In those cases the surgeon may need a different angle, a flexible scope, or an open approach.

The professional caveat: asymptomatic bladder stones found incidentally on imaging are not automatically treated. Small stones in patients who empty well and have no infection may be monitored, because the risk of intervention can exceed the risk of the stone. The decision hinges on symptoms, infection history, and whether the bladder empties.

Misconceptions worth correcting

Bladder stones and kidney stones are not the same disease, and their removal differs. Kidney stones are often treated with shockwave lithotripsy from outside the body or with ureteroscopy; bladder stones are almost never treated with external shockwave lithotripsy in modern practice, because the bladder is a large, mobile reservoir and focusing shockwaves on a stone inside it is unreliable and can injure surrounding tissue.

Another misconception: drinking more water will flush a bladder stone out. Increased fluid intake helps prevent stones, but it cannot overcome the anatomical or functional obstruction that traps a stone in the bladder. In fact, in a patient with poor bladder emptying, aggressive hydration without a drainage plan can worsen retention.

A third: cystolitholapaxy is "just" a scope procedure, so it must be minor. It is minimally invasive compared with open surgery, but it still requires anesthesia, carries risks of bladder perforation, bleeding, infection, and urethral injury, and demands a surgeon skilled at intracorporeal fragmentation. Treat it as real surgery with real recovery.

Red flags that warrant prompt evaluation rather than watchful waiting:

Visible blood in the urine that persists beyond a few days or clots Fever, chills, or flank pain suggesting upper urinary tract infection Sudden inability to urinate (acute retention) Recurrent urinary tract infections, especially with struvite or urease-producing organisms A known stone plus new incontinence or pelvic pain

Practical actions and thresholds

If a bladder stone is suspected, the diagnostic path is straightforward. Urinalysis and urine culture identify infection and crystals. Ultrasound of the bladder is often first-line because it is radiation-free and shows stones and post-void residual volume. Non-contrast CT of the abdomen and pelvis is more sensitive and characterizes stone size and location. Cystoscopy confirms the diagnosis and lets the surgeon plan the approach.

Concrete steps:

Document stone size and number on imaging; size determines approach as above. Assess bladder emptying with a post-void residual; a large residual supports an obstruction or neurogenic cause. Treat infection before elective instrumentation when possible; active urinary infection raises the risk of sepsis during cystolitholapaxy. Ask whether prostate obstruction is present; if so, plan for concomitant or staged outlet surgery. Confirm stone composition after extraction, because struvite signals infection-related stone disease and a recurrence-prevention plan. Arrange follow-up imaging or cystoscopy if symptoms persist, since residual fragments can seed new stones.

Prevention after removal focuses on the cause: treating obstruction, optimizing bladder emptying, managing infection, and maintaining hydration. For struvite stones, complete removal matters because residual fragments can perpetuate infection. For uric acid stones, urine alkalinization may be considered, though this is a physician-directed decision.

Limitations of the evidence: much of the comparative data on cystolitholapaxy versus percutaneous or open surgery comes from single-center series with heterogeneous stone populations, so thresholds such as "3 cm" or "5 cm" are practical conventions rather than sharp biological boundaries. Device choice is often dictated by what a hospital owns and what the surgeon trained on, not by head-to-head trials. And because bladder stones are less common than kidney stones, large randomized comparisons are scarce.

The bottom line: removal is usually endoscopic fragmentation and extraction, sized to the stone, with the durability of the result depending as much on correcting the underlying bladder problem as on the procedure itself.